CK
Chandan Kumar
About Chandan Kumar
Data last updated:
Chandan Kumar is a Director at Ducwin Healthcare Private Limited (since 2021) and Director at Ducwin Pharmaceuticals Private Limited (since 2018). The companies operate in Business Services and Trading. The 2 current companies with reported revenue have a combined latest revenue of ₹2.24 Cr; the largest is Ducwin Healthcare Private Limited at ₹2.00 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 11 Sep 2021 | 2021 | ₹2.00 Cr (FY 2025) | Active | |
| Director | 22 Nov 2018 | 2018 | ₹23.5 Lakh (FY 2020) | Active |
Board colleagues of Chandan Kumar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Simran | 09315372 | Ducwin Healthcare Private Limited | Director |
| Rahul Kumar Ram | 08285022 | Ducwin Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Chandan Kumar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Chandan Kumar
Chandan Kumar currently holds 2 directorships: Ducwin Healthcare Private Limited (Director, since 11 Sep 2021, revenue ₹2.00 Cr (FY 2025)); Ducwin Pharmaceuticals Private Limited (Director, since 22 Nov 2018, revenue ₹23.5 Lakh (FY 2020)).
Chandan Kumar was first appointed on 22 Nov 2018 as Director at Ducwin Pharmaceuticals Private Limited. The most recent appointment on record is 11 Sep 2021 at Ducwin Healthcare Private Limited.
The 2 current companies of Chandan Kumar that report revenue have a combined latest revenue of ₹2.24 Cr: Ducwin Healthcare Private Limited ₹2.00 Cr (FY 2025); Ducwin Pharmaceuticals Private Limited ₹23.5 Lakh (FY 2020).
The current boards of Chandan Kumar's companies include Simran (Ducwin Healthcare Private Limited), Rahul Kumar Ram (Ducwin Pharmaceuticals Private Limited).